Cumberland Pharmaceuticals/$CPIX
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
- Ticker
- $CPIX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 88
- Headquarters
- Nashville, United States
- Website
- www.cumberlandpharma.com
CPIX Metrics
BasicAdvanced
$92M
1.32
$4.63
-
$1.50
24.51%
Price and volume
Market cap
$92M
52-week high
$9.28
52-week low
$1.85
Average daily volume
151K
Dividend rate
$1.50
Financial strength
Current ratio
3.046
Quick ratio
3.021
Long term debt to equity
0.056
Total debt to equity
0.064
Dividend payout ratio (TTM)
32.67%
Interest coverage (TTM)
-4.38%
Profitability
EBITDA (TTM)
1.972
Gross margin (TTM)
83.30%
Net profit margin (TTM)
148.63%
Operating margin (TTM)
-4.70%
Effective tax rate (TTM)
-2.14%
Revenue per employee (TTM)
$530,000
Management effectiveness
Return on assets (TTM)
-1.51%
Return on equity (TTM)
-3.40%
Valuation
Price to earnings (TTM)
1.323
Price to revenue (TTM)
1.966
Price to book
1.27
Price to tangible book (TTM)
1.27
Price to free cash flow (TTM)
-84.539
Free cash flow yield (TTM)
-1.18%
Free cash flow per share (TTM)
-0.072
Dividend yield (TTM)
24.51%
Growth
Revenue change (TTM)
140.15%
Earnings per share change (TTM)
-2,144.34%
3-year revenue growth (CAGR)
5.59%
10-year revenue growth (CAGR)
3.77%
3-year earnings per share growth (CAGR)
200.44%
10-year earnings per share growth (CAGR)
110.62%
CPIX Financial Performance
Revenues and expenses
Upcoming events
No upcoming events
CPIX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.